Treatment With Intent to Generate Endovascular Reperfusion
Public ClinicalTrials.gov record NCT03474549. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Tigertriever is a CE marked mechanical revascularization device indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset. Patients who are ineligible for IV t-PA or who fail IV t-PA therapy are candidates for treatment. The objective of the TIGER Study is to evaluate the safety and effectiveness of the Tigertriever device in restoring blood flow in the neurovasculature by removing thrombus in patients experiencing ischemic stroke due to a large vessel occlusion (LVO). This study is designed to support substantial equivalence to approved and marketed products such as the Solitaire or Trevo Retriever.
Study identification
- NCT ID
- NCT03474549
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 160 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 8, 2018
- Primary completion
- Apr 14, 2020
- Completion
- Jun 29, 2020
- Last update posted
- May 7, 2024
2018 – 2020
United States locations
- U.S. sites
- 16
- U.S. states
- 10
- U.S. cities
- 15
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| UCLA medical center | Los Angeles | California | 90095 | — |
| Los Robles | Thousand Oaks | California | 91360 | — |
| Tenet Health | Coral Springs | Florida | 33076 | — |
| Baptist Health Research Institute | Jacksonville | Florida | 32207 | — |
| Baptist Health South Florida | Miami | Florida | 33176 | — |
| University of Miami | Miami | Florida | 33316 | — |
| WellStar Research Institute | Marietta | Georgia | 30060 | — |
| University of Iowa | Iowa City | Iowa | 52242 | — |
| University of Massachusetts | Worcester | Massachusetts | 01655 | — |
| Maimonides Medical Center | Brooklyn | New York | 11219 | — |
| University of Buffalo | Buffalo | New York | 14203 | — |
| Riverside Methodist Hospital | Columbus | Ohio | 43214 | — |
| Mercy Health | Toledo | Ohio | 43604 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| UPMC | Pittsburgh | Pennsylvania | 15213 | — |
| VBMC Harlingen | Harlingen | Texas | 78550 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03474549, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2024 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03474549 live on ClinicalTrials.gov.